Capital Partners Llc Aisling, 10% Owner at Esperion Therapeutics, Inc. (ESPR), sold 217,469 shares at $106.10 ($23.5M) on 2015-04-24, disclosed to the SEC on 2015-04-27.
Open-market sale of $23.5M ESPR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $109.10 | 150,000 | $16.4M | 69.5% |
| 2 | $106.10 | 61,726 | $6.5M | 27.8% |
| 3 | $108.00 | 5,743 | $620K | 2.6% |
| Total | $108.22 avg | 217,469 | $23.5M | 100% |